Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeWages, Salaries and Other
Others
Ratios

Nu-Med Plus (NUMD) Net Income towards Common Stockholders (2016 - 2021)

Nu-Med Plus' Net Income towards Common Stockholders history spans 10 years, with the latest figure at -$112341.0 for Q4 2021.

  • Quarterly results put Net Income towards Common Stockholders at -$112341.0 for Q4 2021, up 77.87% from a year ago — trailing twelve months through Dec 2021 was -$830061.0 (up 58.98% YoY), and the annual figure for FY2025 was -$56182.0, up 17.8%.
  • Net Income towards Common Stockholders for Q4 2021 was -$112341.0 at Nu-Med Plus, up from -$118366.0 in the prior quarter.
  • In the past five years, Net Income towards Common Stockholders ranged from a high of $3.9 million in Q4 2017 to a low of -$908467.0 in Q2 2020.
  • The 5-year median for Net Income towards Common Stockholders is -$186876.0 (2018), against an average of -$73178.8.
  • The sharpest move saw Net Income towards Common Stockholders surged 315.48% in 2017, then tumbled 290.35% in 2018.
  • Year by year, Net Income towards Common Stockholders stood at $3.9 million in 2017, then crashed by 108.99% to -$350509.0 in 2018, then skyrocketed by 40.12% to -$209881.0 in 2019, then tumbled by 141.9% to -$507696.0 in 2020, then soared by 77.87% to -$112341.0 in 2021.
  • According to Business Quant data, Net Income towards Common Stockholders over the past three periods came in at -$112341.0, -$118366.0, and -$242606.0 for Q4 2021, Q3 2021, and Q2 2021 respectively.